CoChat

Nalmefene: Intravenous safety and kinetics of a new opioid antagonist

Dixon, Ross, Howes, John, Gentile, Joseph, Hsu, Hon-Bin, Hsiao, Jane, Garg, Dyal, Weidler, Donald, Meyer, Marvin, Tuttle, Ronald · 1986 · Clinical Pharmacology and Therapeutics
Cited by 98

The DOI matches its Crossref record.

Abstract

In a placebo-controlled, double-blind study we evaluated the safety and kinetics of a new narcotic antagonist, nalmefene, after 2, 6, 12, and 24 mg intravenous doses to healthy men. At each dose level four subjects received active drug and two received placebo. The drug was well tolerated at all dose levels with only mild and transient side effects, the most common of which was lightheadedness. The plasma concentration-time data were best fit with a triexponential equation, and the terminal elimination phase had a harmonic mean t1/2 of 8 to 9 hours. Only about 5% of the dose was excreted in the urine as intact nalmefene, with up to 60% excreted as nalmefene glucuronide. Although intersubject differences were noted, mean or dose-normalized mean kinetic parameters such as clearance, steady-state volume of distribution, terminal t1/2, and AUC showed no consistent trends related to increasing doses, indicating that nalmefene has linear pharmacokinetics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/clpt.1986.9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 98

Metadata

Authors
Dixon, R., Howes, J., Gentile, J., Hsu, H.-B., Hsiao, J., Garg, D., Weidler, D., Meyer, M., & Tuttle, R.
Venue
Clinical Pharmacology and Therapeutics
Publisher
Wiley
Published
1986-01
Volume
39
Issue
1
Pages
49-53
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W1975183736
Cited by
98
References
0
FWCI
6.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nalmefene: Intravenous safety and kinetics of a new opioid antagonist. https://app.cochat.ai/papers/10.1038/clpt.1986.9
The paper
Dixon, R., Howes, J., Gentile, J., Hsu, H.-B., Hsiao, J., Garg, D., Weidler, D., Meyer, M., & Tuttle, R. (1986). Nalmefene: Intravenous safety and kinetics of a new opioid antagonist. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.1986.9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.